Article
Epigenetic silencing of miRNA-338-5p and miRNA-421 drives SPINK1-positive prostate cancer
2018-07-24
Abstract excerpt
<h4>Purpose</h4> Serine Peptidase Inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most recurrent and aggressive prostate cancer (PCa) subtype. However, the underlying molecular mechanism and pathobiology of SPINK1 in PCa remains largely unknown. <h4>Experimental Design</h4> MicroRNA-prediction tools were employed to examine the SPINK1- 3’UTR for miRNAs binding. Luciferase reporter assays were...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b315e886-0264-54c5-b57e-f32e57204d30
- DOI
- 10.1101/376277
